Fortress Biotech
FBIO
#9428
Rank
A$79.18 M
Marketcap
$2.87
Share price
2.87%
Change (1 day)
-41.77%
Change (1 year)

Operating Margin for Fortress Biotech (FBIO)

Operating Margin as of December 2024 (TTM): -196.92%

According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is -196.92%. At the end of 2022 the company had an Operating Margin of -281.83%.

Operating Margin history for Fortress Biotech from 2016 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-281.83%17.96%
2021-238.92%5.93%
2020-225.55%-18.73%
2019-277.54%-42.96%
2018-486.57%-13.95%
2017-565.46%30.72%
2016-432.58%-93.07%
2015-6,243.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-14,844.40% 7,438.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.92%-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-69.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.88%-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.